The FDA is the one controlling the approval process, not Missling...
No to the following:
Do you think that this communication/ data misunderstanding / hit piece debacle will light a fire under TGD and push him to expedite the approval process for Retts?
It's about the accuracy of the science - not the speed. None of this makes any sense to me.
Perhaps unblind and use an interim look at Excellence data. Or perhaps speed up the release of PDD data to further validate MOA? Or will he just continue on his MO and wait for Excellence/ regular scheduled completion of trials (whenever the hell that will be)?